Save to Existing Project
Save to a New Project
UniversitÃ© Libre de Bruxelles
The invention provides an improved signature for prognostic of Breast Cancer outcome based on the organized anti-tumor immune response of patients. The so-called Immunological Grade relies on the combination of a molecular score from a 8-gene signature as
STATE OF THE ART
Although CD8+ cytotoxic T cells have been considered as the key component of effective anti-tumor immunity, and breast tumors with higher levels of infiltrating CD8+ T cells have been associated with better patient survival, studies have also shown that CD8+ T cells frequently fail to fully function in vivo if there is a lack of adequate CD4+ T cell help. The role played by individual CD4+T (Th) subsets in cancer immunity remains however largely controversial.
The invention provides an improved signature for prognostic of Breast Cancer outcome based on the organized anti-tumor immune response of patients. The so-called Immunological Grade relies on the combination of a molecular score from a 8-gene signature associated with follicular helper T (Tfh) cells and a morphological score based on the density of tumor infiltrating lymphocites (TIL) and the detection of organized tertiary lymphoid structures (TLS). It has been designed to reflect patients' intrinsic immune response at diagnosis and to provide thereby powerful means to predict survival as well as preoperative response to chemotherapy.
The Immunological Grade (IG) can be effectively used to stratify Breast Cancer (BC) patients for treatment, especially with respect to preoperative response to chemotherapy in the context of neo-adjuvant therapy. IG is particularly well-suited to complement the service/product portfolio of genomics service providers and pharma industries involved in the development of new BC therapies.
KEY ADVANTAGES OF THE Description of Technology
- IG outperforms current immune signature
- Provides Strong Prognostic Power for HER2+ subtype
- Relies on standardized routinely available detection
Type of Business Relationship Sought
License Agreement, Product Co-Development
Last Updated Sep 2014